Authors: Abramovitz, M Adam, M Boie, Y Carriere, MC Denis, D Godbout, C Lamontagne, S Rochette, C Sawyer, N Tremblay, NM Belley, M Gallant, M Dufresne, C Gareau, Y Ruel, R Juteau, H Labelle, M Ouimet, N Metters, KM

Citation: M. Abramovitz et al., The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs, BBA-MOL C B, 1483(2), 2000, pp. 285-293

Authors: Bayly, CI Black, WC Leger, S Ouimet, N Ouellet, M Percival, MD

Citation: Ci. Bayly et al., Structure-based design of COX-2 selectivity into flurbiprofen, BIOORG MED, 9(3), 1999, pp. 307-312

Authors: Ouimet, N Chan, CC Charleson, S Claveau, D Gordon, R Guay, D Li, CS Ouellet, M Percival, DM Riendeau, D Wong, E Zamboni, R Prasit, P

Citation: N. Ouimet et al., Substituted heterocyclic analogs as selective COX-2 inhibitors in the Flosulide class, BIOORG MED, 9(2), 1999, pp. 151-156

Authors: Zhaol, DL Xu, F Chen, CY Tillyer, RD Grabowski, EJJ Reider, PJ Black, C Ouimet, N Prasit, P

Citation: Dl. Zhaol et al., Efficient syntheses of 2-(3 ',5 '-difluorophenyl)-3-(4 '-methylsulfonylphenyl)-cyclopent-2-enone, a potent COX-2 inhibitor, TETRAHEDRON, 55(19), 1999, pp. 6001-6018

Authors: Black, WC Brideau, C Chan, CC Charleson, S Chauret, N Claveau, D Ethier, D Gordon, R Greig, G Guay, J Hughes, G Jolicoeur, P Leblanc, Y Nicoll-Griffith, D Ouimet, N Riendeau, D Visco, D Wang, ZY Xu, L Prasit, P

Citation: Wc. Black et al., 2,3-diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors, J MED CHEM, 42(7), 1999, pp. 1274-1281